Academic Journal

Occurrence and number of immune-related adverse events are independently associated with survival in advanced non-small-cell lung cancer treated by nivolumab

التفاصيل البيبلوغرافية
العنوان: Occurrence and number of immune-related adverse events are independently associated with survival in advanced non-small-cell lung cancer treated by nivolumab
المؤلفون: Bouhlel, Linda, Doyen, Jérôme, Chamorey, Emmanuel, Poudenx, Michel, Ilie, Marius, Gal, Jocelyn, Guigay, Joël, Benzaquen, Jonathan, Marquette, Charles-Hugo, Berthet, Jean-Philippe, Mouroux, Jérôme, Schiappa, Renaud, Padovani, Bernard, Hofman, Paul, Otto, Josiane
المصدر: Bulletin du Cancer ; volume 107, issue 9, page 946-958 ; ISSN 0007-4551
بيانات النشر: Elsevier BV
سنة النشر: 2020
المجموعة: ScienceDirect (Elsevier - Open Access Articles via Crossref)
نوع الوثيقة: article in journal/newspaper
اللغة: English
DOI: 10.1016/j.bulcan.2020.04.019
الاتاحة: http://dx.doi.org/10.1016/j.bulcan.2020.04.019
https://api.elsevier.com/content/article/PII:S0007455120302630?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S0007455120302630?httpAccept=text/plain
Rights: https://www.elsevier.com/tdm/userlicense/1.0/ ; http://www.elsevier.com/open-access/userlicense/1.0/
رقم الانضمام: edsbas.B34442DC
قاعدة البيانات: BASE
الوصف
DOI:10.1016/j.bulcan.2020.04.019